COT, cross-over trial; RCT, randomized controlled trial.

Renexxion, Inc. is a clinical-stage biopharmaceutical company pioneering therapies for gastrointestinal (GI) disorders. Renexxion’s lead compound, naronapride, is a potential best-in-class, highly ...

Autonomous AI agents inhabit virtual worlds, shaping economies, solving challenges, and driving ... [+] innovation—showing us a future where machines collaborate and create without human ...

Oral protocols most often used barbiturates alone (37/163) or in conjunction with an opioid medication (7/163) and often recommended using a prokinetic agent prior to lethal drug ingestion.

An NHS doctor has suggested a common sweet that's readily available from supermarkets can help to relieve constipation and ...

Renexxion’s lead compound, naronapride, is a potential best-in-class, highly selective dual-action 5-HT4 agonist/D2-antagonist prokinetic agent designed to enhance GI motility with minimal systemic ...

Renexxion's lead compound, naronapride, is a potential best-in-class, highly selective dual-action 5-HT4 agonist/D2-antagonist prokinetic agent designed to enhance GI motility with minimal systemic ...

A centralized area for installable Mythic Agents based on https://github.com/MythicMeta/Mythic_External_Agent ...

To arrive at this list, we sent surveys to more than 50,000 Washingtonian subscribers and nearly 2,000 agents who made last year’s Best Agents and Top Producers lists. We asked both groups for the ...